Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease characterised by fibrosis of the lung parenchyma and loss of lung function. Although the pathogenic pathways involved in IPF have not been fully elucidated, IPF is believed to be caused by repetitive alveolar epithelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollin, Lutz, Wex, Eva, Pautsch, Alexander, Schnapp, Gisela, Hostettler, Katrin E., Stowasser, Susanne, Kolb, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416110/
https://www.ncbi.nlm.nih.gov/pubmed/25745043
http://dx.doi.org/10.1183/09031936.00174914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416110/
https://www.ncbi.nlm.nih.gov/pubmed/25745043
http://dx.doi.org/10.1183/09031936.00174914

Ejemplares similares